<DOC>
	<DOC>NCT02181959</DOC>
	<brief_summary>The purpose of this trial was to evaluate the safety and tolerability of a galenic formulation of PharmatonÂ® capsules containing 2-Dimethylaminoethanol (DMAE) in healthy volunteers.</brief_summary>
	<brief_title>Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy man or woman, between 20 to 70 years Fit to work Volunteers have given informed consent and signed the consent form Any serious disorder that might interfere with his/her participation in this study and the evaluation of the safety of the test drug (e.g. renal insufficiency, hepatic dysfunction, cardiovascular disease, disorders of the calcium metabolism, hypervitaminosis A or D, psychic disorder, etc) Treatment with other drugs that might interfere with the evaluation of the safety of the test drug Known hypersensitivity to any ingredients of the study drug Pregnancy, lactation, women of childbearing potential who do not use an established contraceptive Drug and alcohol abuse Participation in another trial Known abnormal values of the laboratory tests (if detected after enrolment, subjects will continue the treatment provided there are no medical objections)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>